Skip to main content
. 2015 May 21;5:10338. doi: 10.1038/srep10338

Table 1. Characteristics of studies included in the meta-analysis.

First author year Country or area Duration Month(s) Histology Stage Patients n Quality score Detection Cutoff values
Andersen16 2011 Norway 216 NSCLC I-IIIA 335 9 IHC (Notch1, DLL4) Staining of H-score 0–1 vs. 2–3
Baumgart8 2010 Germany NR NSCLC NR 46 9 IHC(Notch1) Staining of H-score 0–1 vs. 2–3
Bild17 2005 USA 90 NSCLC NR 111 9 RT-PCR(Notch1, DLL4, HES1) median expression
Cao9 2012 China NR NSCLC I-IIIA 131 8 IHC(Notch1) Staining of H-score0–1 vs. 2–3
Hassan23 2013 USA 60 ADC I-III 441 9 IHC(HES1) median H-score
Hou20 2010 Netherland 130 NSCLC NR 156 9 RT-PCR (Notch1, HES1) median expression
Lee24 2008 Korea NR NSCLC I-III 158 8 IHC(Notch1) >10%
Li10 2009 USA NR NSCLC NR 127 9 IHC(Notch1) median H-score
Li11 2010 USA NR NSCLC I-IV 395 8 IHC(Notch1) Staining of H-score 0–1 vs. 2–3
Okayama18 2011 Japan 120 ADC NR 226 9 RT-PCR(Notch1, DLL4, HES1) median expression
Peng12 2011 China NR NSCLC NR 55 7 IHC(Notch1) median H-score
Pesch13 2012 Germany NR NSCLC NR 68 7 IHC(Notch1) Staining of H-score 0–1 vs. 2–3
Raponi22 2006 USA 60 SCC I-IIIA 20 7 RT-PCR(HES1) median expression
Shi28 2014 China 24 NSCLC III-IV 594 8 IHC(Notch3) median H-score
Westhoff19 2009 Italy 60 NSCLC I-IV 420 9 IHC(Notch1) median H-score
Xin14 2007 China NR NSCLC I-III 80 8 IHC(Notch1) Staining of H-score 0–1 vs. 2–3
Ye27 2013 China 60 NSCLC I-IV 131 8 IHC(Notch3) median H-score
Zhang15 2013 USA NR NSCLC I-IV 41 8 IHC(Notch1) Staining of H-score 0–1 vs. 2–3
Zhu21 2010 Canada 120 NSCLC I-II 133 9 RT-PCR(HES1) median expression

Abbreviation: NR, not reporting; IHC, immunohistochemistry; RT-PCR, real-time reverse transcription polymerase chain reaction; ADC, lung adenocarcinoma; SCC, lung squamous cell carcinoma.